U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951880) titled 'A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers' on April 23.
Brief Summary: The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.
Study Start Date: June 27
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD4916
AZD4916 will be administered as oral solution.
OTHER: Placebo
Placebo will be administered as oral solution.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....